JPH042595B2 - - Google Patents

Info

Publication number
JPH042595B2
JPH042595B2 JP58122900A JP12290083A JPH042595B2 JP H042595 B2 JPH042595 B2 JP H042595B2 JP 58122900 A JP58122900 A JP 58122900A JP 12290083 A JP12290083 A JP 12290083A JP H042595 B2 JPH042595 B2 JP H042595B2
Authority
JP
Japan
Prior art keywords
prostaglandin
derivative
nmr
solution
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58122900A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6013779A (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP58122900A priority Critical patent/JPS6013779A/ja
Priority to US06/626,422 priority patent/US4613614A/en
Publication of JPS6013779A publication Critical patent/JPS6013779A/ja
Publication of JPH042595B2 publication Critical patent/JPH042595B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
JP58122900A 1983-07-05 1983-07-05 プロスタグランジンｉ↓２誘導体 Granted JPS6013779A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP58122900A JPS6013779A (ja) 1983-07-05 1983-07-05 プロスタグランジンｉ↓２誘導体
US06/626,422 US4613614A (en) 1983-07-05 1984-06-29 Prostaglandin I2 ester and fat emulsion containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58122900A JPS6013779A (ja) 1983-07-05 1983-07-05 プロスタグランジンｉ↓２誘導体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP21260891A Division JPH04356422A (ja) 1991-07-29 1991-07-29 プロスタグランジンｉ２誘導体含有脂肪乳剤

Publications (2)

Publication Number Publication Date
JPS6013779A JPS6013779A (ja) 1985-01-24
JPH042595B2 true JPH042595B2 (en]) 1992-01-20

Family

ID=14847395

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58122900A Granted JPS6013779A (ja) 1983-07-05 1983-07-05 プロスタグランジンｉ↓２誘導体

Country Status (2)

Country Link
US (1) US4613614A (en])
JP (1) JPS6013779A (en])

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61289034A (ja) * 1985-06-17 1986-12-19 Teijin Ltd イソカルバサイクリン類脂肪乳剤
JP2926749B2 (ja) 1989-04-25 1999-07-28 吉富製薬株式会社 プロスタグランジン含有液状組成物
JPH04342530A (ja) * 1991-04-26 1992-11-30 Teijin Ltd ７−フルオロプロスタサイクリン類脂肪乳剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792410B2 (de) * 1967-09-01 1980-03-13 Apoteksvarucentralen Vitrum Apotekareaktiebolaget, Stockholm Arzneimittelzubereitung zur intravenösen Injektion
JPS53136513A (en) * 1977-05-06 1978-11-29 Ono Pharmaceut Co Ltd Stabilization of prostaglandin-x-related compounds
JPS5446773A (en) * 1977-09-22 1979-04-12 Ono Pharmaceut Co Ltd Prostaglandin i2 analog and its preparation
US4430340A (en) * 1978-07-17 1984-02-07 The Upjohn Company Stabilization of PGI2 compounds with surfactants
JPS5585578A (en) * 1978-12-22 1980-06-27 Toray Ind Inc Prostaglandin i2 derivative
US4303671A (en) * 1980-07-10 1981-12-01 The Upjohn Company Albumin stabilized prostacyclin

Also Published As

Publication number Publication date
JPS6013779A (ja) 1985-01-24
US4613614A (en) 1986-09-23

Similar Documents

Publication Publication Date Title
JP4394170B2 (ja) プロスタグランジン製薬組成物
JPH0326183B2 (en])
SA94150314B1 (ar) مستحلب دوائي pharmaceutical emulsion
US5625083A (en) Dinitroglycerol esters of unsaturated fatty acids and prostaglandins
DK169056B1 (da) Fedtemulsioner indeholdende prostaglandiner I2'er
JPH03204853A (ja) プロスタグランジン類縁体およびその脂肪乳剤
US5690957A (en) Prostaglandin derivatives
EP0051558B1 (de) Prostacyclinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
JPH0330585B2 (en])
JPH042595B2 (en])
EP0144845B1 (en) Indolylacetic acid derivatives and preparations containing same for medical treatments
DE2850304A1 (de) Prostacyclinzwischenprodukte und -analoge
JPH05194524A (ja) 血栓症および血管痙攣症の治療に有用な７−オキサビシクロヘプチル置換複素環式アミドプロスタグランジン類縁体
JPH039907B2 (en])
JPH04356422A (ja) プロスタグランジンｉ２誘導体含有脂肪乳剤
EP0760366B1 (en) Prostaglandin derivatives
JPS6144819A (ja) プロスタグランジンｉ２類縁化合物を含有する循環改善作用を有する薬剤
JPH09124593A (ja) プロスタグランジンｅ１エステル、それらを含有するリポソーム製剤、およびそれらを含有する医薬
JP2802912B2 (ja) プロスタグランジンｅ１エステル、それらを含有するリポソーム製剤、およびそれらを含有する医薬
JPH0244284B2 (en])
JPS6116393B2 (en])
JPH0196158A (ja) 抗炎症剤
JPH0710833A (ja) プロスタグランジン類縁体、その脂肪乳剤およびその用途
Roy et al. Effect of intravenous infusion of OKY-1581 (sodium-(E)-3-[4-(3-pyridylmethyl) phenyl]-2-methylacrylate) on circulatory thromboxane A2 and prostacyclin levels in anaesthetized baboon
WO1990007335A1 (en) Use of isocarbacyclins for preventing or treating organ diseases